PTG
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About

Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation

5/4/2020

 
Picture
Every year, tens of thousands of deaths are due to end-stage heart failure in Europe and in the US combined. Heart transplantation is the ultimate treatment, but its number is dramatically limited due to the shortage of organs in those countries. 
​
​In the same time, the chances of survival beyond one year after transplantation have remained unchanged in recent years, despite significant progress in immunosuppressive therapy and patient care.
One of the most common reasons for long-term graft failure and patient death is an accelerated form of coronary artery disease called cardiac allograft vasculopathy. It is a frequent complication that affects up to half of patients within 10 years following heart transplantation. Yet, until now, little has been known about the different evolutive profiles of cardiac allograft vasculopathy and their risk factors.

An original long-term study at population level on heart transplantation

The Paris Transplant Group, together with researchers from the University Hospitals Leuven and the Cedars-Sinai Medical Center, monitored 1,300+ patients over ten years after heart transplantation. Their research led to the characterisation of different profiles of vasculopathy progression. They just published the results of their study in an article entitled “Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation” in the Circulation journal. 
​
This is one of the largest studies in the field of heart transplantation with a total of 1,301 patients included and 4,710 coronary angiograms analyzed. For the first time, an integrative approach was used to analyze a comprehensive set of clinical, functional, histological and immunological data.

Characterization of 4 trajectories of long-term cardiac allograft vasculopathy progressioN

By applying an unsupervised statistical method in a large European cohort, the researchers were able to identify four distinct patterns of progression of allograft cardiac vasculopathy after the heart transplant (see figure below) that reflect distinct functional, clinical, immunologic, histologic patterns. The four cardiac allograft vasculopathy trajectories showed a gradient of mortality risks

​These cardiac allograft vasculopathy trajectories were validated in an independent North American cohort. The multiple tests and validation processes showed that the identified trajectories and associated variables could be generalized and transportable across different medical centres on different continents. 
​

From this analysis, six candidate variables independently associated with cardiac allograft vasculopathy were identified: donor age, donor gender, donor tobacco consumption, recipient post-transplant dyslipidemia, the presence of anti-HLA donor-specific antibodies and episode of acute cellular rejection during the first year post-transplantation.

Towards individualized monitoring of heart transplant patient

This study has led to an easy-to-use tool for stratifying patient risk for the progression of cardiac allograft vasculopathy over time after heart transplantation. The tool is available online. 
​
Predictive trajectory-based patient monitoring could allow individualization of patient follow-up procedures and medical therapies, thus reducing unnecessary angiograms in low-risk patients and intensifying treatment and angiogram monitoring in high-risk patients. In addition, the patient trajectory assessment that can be performed at an early stage after transplantation may inform the design and optimize endpoint definition of next generation clinical trials.

Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation

Picture
Alexandre Loupy , Guillaume Coutance, Guillaume Bonnet, Jan Van Keer, Marc Raynaud, Olivier Aubert, Marie-Cécile Bories, Maud Racapé, Daniel Yoo, Jean-Paul Duong Van Huyen, Patrick Bruneval, Jean-Luc Taupin, Carmen Lefaucheur, Shaida Varnous, Pascal Leprince, Romain Guillemain, Jean-Philippe Empana, Ryan Levine, Maarten Naesens, Jignesh K. Patel, Xavier Jouven, and Jon Kobashigawa 

Originally published on 4 May 2020 on Circulation, https://doi.org/10.1161/CIRCULATIONAHA.119.044924
Read the publication

Comments are closed.

    Paris Transplant Group

    Our global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field by filling the gap between basic science and applied biomedical researches.

    CATEGORIES

    Awards
    Events
    Job offers
    Press Releases
    Publications

    See also

    Press coverage
    Video and ​Picture gallery

    ALl

    All
    Alexandre Loupy
    Antoine Bouquegneau
    Antoine Durrbach
    Antoine Roux
    Awards
    Blaise Robin
    Carmen Lefaucheur
    Charlotte Debiais
    Charlotte Loheac
    Christophe Legendre
    Daniel Yoo
    Dany Anglicheau
    Denis Glotz
    Denis Viglietti
    Elodie Bailly
    Events
    Gillian Divard
    Guillaume Bonnet
    Guillaume Coutance
    Huanxi Zhang
    Jean Luc Taupin
    Jean Paul Duong Van Huyen
    Jean Philippe Empana
    Jessy Dagobert
    Job
    Juliette Gueguen
    Kevin Louis
    Marc Raynaud
    Marie-Cécile Bories
    Marion Rabant
    Maud Racape
    Michel Delahousse
    Olivier Aubert
    Pascal Leprince
    Patrick Bruneval
    Peter Reese
    Press Releases
    Publications
    Shaida Varnous
    Valentin Goutaudier
    Xavier Jouven
    Yassine Bouatou
    Zeynep Demir

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    March 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    March 2019
    February 2019
    December 2018
    September 2018
    May 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    June 2016
    April 2016
    October 2015
    June 2015
    August 2014
    January 2014
    September 2013
    January 2013
    June 2011
    August 2010
    May 2009

    RSS Feed

Research

iBox technology
PTG Research
PTG Publications
Technical platforms​
Database resources
Covid-related research 🔓

Partnerships

Research collaborations
Technical platforms
​Database access
​

Paris Transplant Group

About PTG
PTG Team
​​Careers at PTG
​
Latest News
Video and Picture Gallery

PTG in the Press
​Contact us

Search

LEGAL NOTICE AND PRIVACY POLICY
© COPYRIGHT 2019. ALL RIGHTS RESERVED.

 LABS EXPLORER for the PARIS TRANSPLANT GROUP.
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About